Cytraze 1000mg Injection
Marketer
Khandelwal Laboratories Pvt Ltd
Salt Composition
Cytarabine (1000mg)
Overview Cytraze 1000mg Injection
Hemocyte 1000mg Injection is indicated for the management of specific hematologic malignancies. Its application may extend to other conditions as directed by a physician, potentially as a component of combination chemotherapy regimens. Administration is intravenous or subcutaneous, performed by a healthcare provider. Dosage and frequency are individualized by your doctor based on your condition and may be adjusted. Strict adherence to the prescribed regimen is crucial, as incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be immediately apparent, often requiring weeks or months; discontinue use only under medical supervision. Frequently reported side effects include dermatological reactions (rash, ulceration), gastrointestinal upset (nausea, vomiting), and alopecia. Hemocyte 1000mg Injection can suppress hematopoiesis, increasing infection and bleeding risks. Report symptoms such as chills, unusual hemorrhage, ecchymosis, or melena promptly. Regular monitoring of blood counts, cardiac function, hepatic function, and uric acid levels is essential. Prior to treatment, disclose any pre-existing bleeding disorders, hepatic or renal impairment, or concurrent use of antimicrobial agents. Drug interactions are possible; inform your doctor of all medications currently in use. This medication is contraindicated during gestation and lactation. Reliable contraception is recommended for both partners throughout the treatment period to prevent conception.
Primary Ingredients of Cytraze 1000mg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Cytraze 1000mg Injection
Hematological malignancy
Major Benefits of Cytraze 1000mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cytraze 1000mg Injection:
- Rash
- Skin ulcer
- Nausea
- Vomiting
- Hair loss
- Abdominal pain
- Anal ulcers
- Anemia (low number of red blood cells)
- Decreased white blood cell count
- Fever
- Infection
- Abnormal liver function
- Low blood platelets
- Mouth ulcer
- Pneumonia
- Sepsis
- Mouth sore
- Stomatitis (Inflammation of the mouth)
How to use Cytraze 1000mg Injection:
This medication will be administered by your physician or their qualified associate; self-medication is strictly prohibited.
How Cytraze 1000mg Injection works:
Cytraze 1000mg Injection halts cancer cell proliferation by disrupting DNA and RNA synthesis through nucleotide replacement. This action inhibits cancerous growth and replication.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol and Cytraze 1000mg Injection is undefined regarding safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Cytraze 1000mg Injection during pregnancy carries established risks to fetal development and is therefore contraindicated. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Cytraze 1000mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Cytraze 1000mg Injection might lead to adverse reactions that could impair driving capabilities.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Cytraze 1000mg Injection without a recommended dosage change. Nevertheless, consultation with a physician is advised for individuals with pre-existing kidney conditions.
LiverCONSULT YOUR DOCTOR
Data regarding Cytraze 1000mg Injection use in patients exhibiting hepatic impairment is scarce. Physician consultation is advised. Due to this data deficiency, a conservative approach to administering Cytraze 1000mg Injection is suggested for patients with liver disease.
What if you forget to take Cytraze 1000mg Injection :
NA
Facts to Know About Cytraze 1000mg Injection
| Label | Value |
|---|---|
| Chemical Type | Pyrimidine-based Nucleoside Analogue |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Metabolic inhibitors |

